ResearchIn-Press PreviewImmunologyInfectious diseasePulmonology
Open Access |
10.1172/jci.insight.198551
1Division of Pulmonary and Critical Care Medicine, Department of Internal Me, University of Michigan, Ann Arbor, United States of America
2Human Genetics, University of Michigan, Ann Arbor, United States of America
3Department of Nephrology, University Hospital Regensburg, Regensburg, Germany
4Department of Pathology, University of Michigan, Ann Arbor, United States of America
5VA Center for Clinical Management Research, Ann Arbor, United States of America
6Board of Governors Regenerative Medicine Institute and Department of Biomed, Cedars-Sinai Medical Center, Los Angeles, United States of America
Find articles by Denstaedt, S. in: PubMed | Google Scholar
1Division of Pulmonary and Critical Care Medicine, Department of Internal Me, University of Michigan, Ann Arbor, United States of America
2Human Genetics, University of Michigan, Ann Arbor, United States of America
3Department of Nephrology, University Hospital Regensburg, Regensburg, Germany
4Department of Pathology, University of Michigan, Ann Arbor, United States of America
5VA Center for Clinical Management Research, Ann Arbor, United States of America
6Board of Governors Regenerative Medicine Institute and Department of Biomed, Cedars-Sinai Medical Center, Los Angeles, United States of America
Find articles by McBean, B. in: PubMed | Google Scholar
1Division of Pulmonary and Critical Care Medicine, Department of Internal Me, University of Michigan, Ann Arbor, United States of America
2Human Genetics, University of Michigan, Ann Arbor, United States of America
3Department of Nephrology, University Hospital Regensburg, Regensburg, Germany
4Department of Pathology, University of Michigan, Ann Arbor, United States of America
5VA Center for Clinical Management Research, Ann Arbor, United States of America
6Board of Governors Regenerative Medicine Institute and Department of Biomed, Cedars-Sinai Medical Center, Los Angeles, United States of America
Find articles by Boyle, A. in: PubMed | Google Scholar
1Division of Pulmonary and Critical Care Medicine, Department of Internal Me, University of Michigan, Ann Arbor, United States of America
2Human Genetics, University of Michigan, Ann Arbor, United States of America
3Department of Nephrology, University Hospital Regensburg, Regensburg, Germany
4Department of Pathology, University of Michigan, Ann Arbor, United States of America
5VA Center for Clinical Management Research, Ann Arbor, United States of America
6Board of Governors Regenerative Medicine Institute and Department of Biomed, Cedars-Sinai Medical Center, Los Angeles, United States of America
Find articles by Arenberg, B. in: PubMed | Google Scholar
1Division of Pulmonary and Critical Care Medicine, Department of Internal Me, University of Michigan, Ann Arbor, United States of America
2Human Genetics, University of Michigan, Ann Arbor, United States of America
3Department of Nephrology, University Hospital Regensburg, Regensburg, Germany
4Department of Pathology, University of Michigan, Ann Arbor, United States of America
5VA Center for Clinical Management Research, Ann Arbor, United States of America
6Board of Governors Regenerative Medicine Institute and Department of Biomed, Cedars-Sinai Medical Center, Los Angeles, United States of America
Find articles by
Mack, M.
in:
PubMed
|
Google Scholar
|
1Division of Pulmonary and Critical Care Medicine, Department of Internal Me, University of Michigan, Ann Arbor, United States of America
2Human Genetics, University of Michigan, Ann Arbor, United States of America
3Department of Nephrology, University Hospital Regensburg, Regensburg, Germany
4Department of Pathology, University of Michigan, Ann Arbor, United States of America
5VA Center for Clinical Management Research, Ann Arbor, United States of America
6Board of Governors Regenerative Medicine Institute and Department of Biomed, Cedars-Sinai Medical Center, Los Angeles, United States of America
Find articles by
Moore, B.
in:
PubMed
|
Google Scholar
|
1Division of Pulmonary and Critical Care Medicine, Department of Internal Me, University of Michigan, Ann Arbor, United States of America
2Human Genetics, University of Michigan, Ann Arbor, United States of America
3Department of Nephrology, University Hospital Regensburg, Regensburg, Germany
4Department of Pathology, University of Michigan, Ann Arbor, United States of America
5VA Center for Clinical Management Research, Ann Arbor, United States of America
6Board of Governors Regenerative Medicine Institute and Department of Biomed, Cedars-Sinai Medical Center, Los Angeles, United States of America
Find articles by Newstead, M. in: PubMed | Google Scholar
1Division of Pulmonary and Critical Care Medicine, Department of Internal Me, University of Michigan, Ann Arbor, United States of America
2Human Genetics, University of Michigan, Ann Arbor, United States of America
3Department of Nephrology, University Hospital Regensburg, Regensburg, Germany
4Department of Pathology, University of Michigan, Ann Arbor, United States of America
5VA Center for Clinical Management Research, Ann Arbor, United States of America
6Board of Governors Regenerative Medicine Institute and Department of Biomed, Cedars-Sinai Medical Center, Los Angeles, United States of America
Find articles by Deng, Y. in: PubMed | Google Scholar
1Division of Pulmonary and Critical Care Medicine, Department of Internal Me, University of Michigan, Ann Arbor, United States of America
2Human Genetics, University of Michigan, Ann Arbor, United States of America
3Department of Nephrology, University Hospital Regensburg, Regensburg, Germany
4Department of Pathology, University of Michigan, Ann Arbor, United States of America
5VA Center for Clinical Management Research, Ann Arbor, United States of America
6Board of Governors Regenerative Medicine Institute and Department of Biomed, Cedars-Sinai Medical Center, Los Angeles, United States of America
Find articles by
Nesvizhskii, A.
in:
PubMed
|
Google Scholar
|
1Division of Pulmonary and Critical Care Medicine, Department of Internal Me, University of Michigan, Ann Arbor, United States of America
2Human Genetics, University of Michigan, Ann Arbor, United States of America
3Department of Nephrology, University Hospital Regensburg, Regensburg, Germany
4Department of Pathology, University of Michigan, Ann Arbor, United States of America
5VA Center for Clinical Management Research, Ann Arbor, United States of America
6Board of Governors Regenerative Medicine Institute and Department of Biomed, Cedars-Sinai Medical Center, Los Angeles, United States of America
Find articles by
Singer, B.
in:
PubMed
|
Google Scholar
|
1Division of Pulmonary and Critical Care Medicine, Department of Internal Me, University of Michigan, Ann Arbor, United States of America
2Human Genetics, University of Michigan, Ann Arbor, United States of America
3Department of Nephrology, University Hospital Regensburg, Regensburg, Germany
4Department of Pathology, University of Michigan, Ann Arbor, United States of America
5VA Center for Clinical Management Research, Ann Arbor, United States of America
6Board of Governors Regenerative Medicine Institute and Department of Biomed, Cedars-Sinai Medical Center, Los Angeles, United States of America
Find articles by Cano, J. in: PubMed | Google Scholar
1Division of Pulmonary and Critical Care Medicine, Department of Internal Me, University of Michigan, Ann Arbor, United States of America
2Human Genetics, University of Michigan, Ann Arbor, United States of America
3Department of Nephrology, University Hospital Regensburg, Regensburg, Germany
4Department of Pathology, University of Michigan, Ann Arbor, United States of America
5VA Center for Clinical Management Research, Ann Arbor, United States of America
6Board of Governors Regenerative Medicine Institute and Department of Biomed, Cedars-Sinai Medical Center, Los Angeles, United States of America
Find articles by Prescott, H. in: PubMed | Google Scholar
1Division of Pulmonary and Critical Care Medicine, Department of Internal Me, University of Michigan, Ann Arbor, United States of America
2Human Genetics, University of Michigan, Ann Arbor, United States of America
3Department of Nephrology, University Hospital Regensburg, Regensburg, Germany
4Department of Pathology, University of Michigan, Ann Arbor, United States of America
5VA Center for Clinical Management Research, Ann Arbor, United States of America
6Board of Governors Regenerative Medicine Institute and Department of Biomed, Cedars-Sinai Medical Center, Los Angeles, United States of America
Find articles by Goodridge, H. in: PubMed | Google Scholar
1Division of Pulmonary and Critical Care Medicine, Department of Internal Me, University of Michigan, Ann Arbor, United States of America
2Human Genetics, University of Michigan, Ann Arbor, United States of America
3Department of Nephrology, University Hospital Regensburg, Regensburg, Germany
4Department of Pathology, University of Michigan, Ann Arbor, United States of America
5VA Center for Clinical Management Research, Ann Arbor, United States of America
6Board of Governors Regenerative Medicine Institute and Department of Biomed, Cedars-Sinai Medical Center, Los Angeles, United States of America
Find articles by
Zemans, R.
in:
PubMed
|
Google Scholar
|
Published September 24, 2026 - More info
Patients who survive sepsis are predisposed to new hospitalizations for respiratory failure, but the underlying mechanisms are unknown. Using a murine model in which prior sepsis predisposes to enhanced lung injury, we previously discovered that classical monocytes persist in the lungs after long-term recovery from sepsis and exhibit enhanced cytokine expression after secondary challenge with intra-nasal lipopolysaccharide. Here, we hypothesized that immune reprogramming of post-sepsis monocytes and altered ontogeny predispose to enhanced lung injury. Monocyte depletion and/or adoptive transfer was performed three weeks and three months after sepsis. Monocytes from post-sepsis mice were necessary and sufficient for enhanced LPS-induced lung injury and promoted neutrophil degranulation. Prior sepsis enhanced JAK-STAT signaling and AP-1 accessibility in monocytes and shifted monocytes toward the neutrophil-like monocyte lineage. Neutrophil-like monocytes demonstrated a pro-inflammatory phenotype with enhanced IL-1β expression and reduced phagocytic capacity. In human sepsis and/or pneumonia survivors, monocytes were predictive of 90-day mortality and exhibit transcriptional and proteomic neutrophil-like signatures. We conclude that sepsis reprograms monocytes into a pro-inflammatory phenotype and skews bone marrow progenitors and monocytes toward the neutrophil-like lineage, predisposing them to induce neutrophil degranulation and lung injury.